Current Status and Future Prospects of Theranostics with Radiopharmaceuticals

Nuclear medicine is a novel technique of theranostics that uses radiopharmaceuticals. Nuclear medicine dated back to a century ago. Owing to the development of nuclear medicine devices and radiopharmaceuticals, increasing clinical demand, government support, and global cooperations, nuclear medicine...

書目詳細資料
發表在:	Xiehe Yixue Zazhi
Main Authors:	LUO Yaping, LI Fang
格式:	Article
語言:	中文
出版:	Editorial Office of Medical Journal of Peking Union Medical College Hospital 2023-07-01
主題:	radiopharmaceuticals theranostics nuclear medicine
在線閱讀:	https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0236

相似書籍

AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
由: Cyril Fersing, et al.
出版: (2022-02-01)

Strategies for Innovative Development of Tumor-targeted Theranostic Radiopharmaceuticals
由: HUANG Xuhu1, 2, 3, CHEN Huan1, 2, 3, LI Kexin1, 2, 3, WANG Ning1, 2, 3, ZHUANG Jin1, 2, 3, LI Hongyu1, 2, 3, DU Jin2, 3, 4
出版: (2025-04-01)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
由: Arman Rahmim, et al.
出版: (2022-12-01)

Development and Prospect of Theranostic Medical Isotopes and Radiopharmaceuticals in China
由: CHEN Yue
出版: (2022-03-01)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
由: Holis Abdul Holik, et al.
出版: (2022-05-01)

Preclinical Studies of Modern Radiopharmaceuticals: Expert Approaches to Evaluating the Results
由: G. N. Engalycheva, et al.
出版: (2025-09-01)

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions
由: Ajnas Alkatheeri, et al.
出版: (2025-02-01)

Radiopharmaceutical extravasations: a twenty year mini-review
由: Dustin R. Osborne
出版: (2023-07-01)

Embracing artificial intelligence design for better radiopharmaceuticals
由: Jinping Tao, et al.
出版: (2024-08-01)

Editorial: MEDICIS-promed: Advances in radioactive ion beams for nuclear medicine
由: Thierry Stora, et al.
出版: (2022-10-01)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
由: Liesbeth Everix, et al.
出版: (2023-02-01)

Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development
由: Helena Koniar, et al.
出版: (2024-09-01)

Nano-radiopharmaceuticals as therapeutic agents
由: Tanu Dixit, et al.
出版: (2024-03-01)

Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
由: Wiwit Nurhidayah, et al.
出版: (2022-11-01)

Establishing a robust radioligand therapy program: A practical approach for North American centers
由: Erik S. Mittra, et al.
出版: (2024-02-01)

An overview of current phase 3 radiopharmaceutical therapy clinical trials
由: Nicolas Lepareur, et al.
出版: (2025-02-01)

Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
由: Xiaona Sun, et al.
出版: (2024-02-01)

Editorial: Reviews in: Radiopharmaceuticals in nuclear medicine
由: Chuen-Yen Lau, et al.
出版: (2023-03-01)

Nuclear medicine as a tool for diagnosis and targeted cancer therapy
由: V. I. Chernov, et al.
出版: (2018-03-01)

Digital Twins for Personalized Healthcare: Application to Radiopharmaceutical Therapies
由: Hamid Abdollahi, et al.
出版: (2022-12-01)

Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions
由: Hao Fu, et al.
出版: (2023-12-01)

Activities, procedures and doses in pediatric patients due to radiopharmaceuticals
由: Silvia Maria Velasques de Oliveira, et al.
出版: (2008-12-01)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
由: Mai Lin, et al.
出版: (2022-10-01)

QUALITY CONTROL OF RADIOPHARMACEUTICALS IN MEDICAL INSTITUTIONS
由: G. E. Kodina, et al.
出版: (2019-01-01)

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
由: Aryan Golzaryan, et al.
出版: (2025-02-01)

Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines
由: Shijin Xuan, et al.
出版: (2020-01-01)

Preclinical Theranostic Profiling of [<sup>64</sup>Cu]Cu-Acetate in Prostate Cancer
由: Sadaf Ghanaatgar Kasbi, et al.
出版: (2025-10-01)

Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals
由: Xu Zhou, et al.
出版: (2021-11-01)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
由: Melpomeni Fani, et al.
出版: (2017-03-01)

Radiolabeled Liposomes for Nuclear Imaging Probes
由: Ho Ying Low, et al.
出版: (2023-04-01)

Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
由: Syeda Marab Saleem, et al.
出版: (2024-09-01)

Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium
由: Keamogetswe Ramonaheng, et al.
出版: (2024-03-01)

Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
由: Ralph Santos-Oliveira
出版: (2009-12-01)

How to design a theranostic trial?
由: Dheeratama Siripongsatian, et al.
出版: (2024-05-01)

Gold Nanorods as Radiopharmaceutical Carriers: Preparation and Preliminary Radiobiological In Vitro Tests
由: Ludovica Binelli, et al.
出版: (2023-06-01)

Exposing the Rad to Radionuclide: Why Early Education in Theranostics Is Important to Radiologists
由: Andy Ho, et al.
出版: (2025-02-01)

Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities
由: Panoraia I. Siafaka, et al.
出版: (2021-01-01)

Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding
由: Ali Fele-Paranj, et al.
出版: (2024-01-01)

Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals
由: Typhanie Ladrière, et al.
出版: (2023-04-01)

Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
由: Laura De Nardo, et al.
出版: (2024-11-01)